ITGAM and neoplasm: Some of the scRNA-seq findings were validated through flow cytometry, revealing enrichment of CD11b+ and CD206+ as well as CD11b+Ly6G+ cells in CINhigh compared with CINlow tumours (Extended Data Fig. 2a,b).